SCHEMBL29967858

SCHEMBL29967858

CC1(C)Nc2cc(F)c(Br)c(F)c2NC1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21624144 1.00 — —
SCHEMBL23658391 0.86 — —
SCHEMBL29968644 0.86 — —
SCHEMBL29968384 0.81 MOGAT2 (0.33) —
SCHEMBL21624088 0.81 MOGAT2 (0.33) —
SCHEMBL21624193 0.75 TGM2 (0.33) —
SCHEMBL21624008 0.70 — —
SCHEMBL23658709 0.70 MGAT2 (0.37) —
SCHEMBL21624021 0.69 IDO1 (0.31) —
SCHEMBL23648684 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112673009-B Substituted triazoloquinoxaline derivatives 格吕伦塔尔有限公司 2023-09-19 — — CN disclosed
EP-4090661-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
Send feedback